Clinical Trial Update: A Study of AZD4901 in Females With Polycystic Ovary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated AZD4901 in females with Polycystic Ovary Syndrome. The trial is completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• AZD4901

Snippet

Sponsor: AstraZeneca | Conditions: Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder | Phase 2 | Status: COMPLETED | Results posted: 2015-10-12